PR013 (0.045%) — clinical trials using this drug

Public-registry trials using PR013 (0.045%) that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.

Trial	Sponsor	Condition	Phase	Sites
Effectiveness of PR013 Topical Ophthalmic Drops Compared to Vehicle for the Treatment of Allergic Conjunctivitis	Realm Therapeutics, Inc.	Allergic Conjunctivitis	PHASE2	1

Registry history

First registered study	December 2017 — NCT03368339 (Realm Therapeutics, Inc.)
Registered studies matching this name	1 all-time · 0 currently recruiting

Source: ClinicalTrials.gov, the public trial registry.

Free site-risk snapshot for any of these trials

Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Related drugs & trials

Trialed alongside

Other Allergic Conjunctivitis drugs

← Eichor home · All tracked trials · Allergic Conjunctivitis studies · Weekly briefs

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →